{
  "meta": {
    "title": "Gestational_Trophoblastic_Neoplasia",
    "url": "https://brainandscalpel.vercel.app/gestational-trophoblastic-neoplasia-54bba390.html",
    "scrapedAt": "2025-11-29T18:30:48.794Z"
  },
  "questions": [
    {
      "id": 18973,
      "choices": [
        {
          "id": 75852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melanoma</span></span></span></p>"
        },
        {
          "id": 75853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma</span></span></span></p>"
        },
        {
          "id": 75854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
        },
        {
          "id": 75855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bartholin gland adenocarcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72y old woman who preseted with a lesion on the vulva underwent a biopsy. This was diagnosed as squamois cell carcinoma which is the most common pathology in vulvar cancers. Which of the following is the second most common vulvar malignancy and accounts for up to 10 percent of all vulvar cancers?</span></span></p>",
      "unique_key": "Q2730441",
      "question_audio": null,
      "question_video": null,
      "map_id": 31066,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Melanoma</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Of vulvar tumors, approximately 90 percent are squamous cell carcinoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant melanoma is the second most common, but rare histologic subtypes may also be encountered. </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The etiology of vulval cancer is unclear but certain high risk factors are known to be associated</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Postmenopausal women; median age about 60 years</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">White race</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Obesity, Hypertension and Diabetes are known associations</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in nulliparous women</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen sclerosis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (esp high risk types - 16,18)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic vulvar irritation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Premalignant lesions - vulvar intra-epithelial neoplasia</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 707, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75852,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18975,
      "choices": [
        {
          "id": 75860,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen planus</span></span></span></p>"
        },
        {
          "id": 75861,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tobacco abuse </span></span></span></p>"
        },
        {
          "id": 75862,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen sclerosus </span></span></span></p>"
        },
        {
          "id": 75863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Human papillomavirus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 65y postmenopausal woman is dignosed with vulval cancer. She is very surprised as she has been having a very healthy lifestyle. She asks you the risk factors for vulval cancer. Which of the following is not a risk factor for vulval cancer? </span></span></span></p>",
      "unique_key": "Q7622405",
      "question_audio": null,
      "question_video": null,
      "map_id": 31068,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A Lichen planus</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk factors of vulvar cancer are</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in older age (&gt; 60y) and white race</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased association with obesity, HTN, diabetes and nulliparoty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (high risk type 16, 18)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pruritis, chronic irritation of the vulva</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar intra-epithepithelial lesion</span></span></span>&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Lichen planus</strong> may affect the skin anywhere on the body. It affects the mucosal surfaces (oral mucosa) and presents with polygenal flat-topped purpuric plaques. The lesion may be erosive and presents more with pain than pruritus. It is NOT commonly associated with vulvar carcinoma</p>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk factors of vulvar cancer are</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in older age (&gt; 60y) and white race</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased association with obesity, HTN, diabetes and nulliparoty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV (high risk type 16, 18)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pruritis, chronic irritation of the vulva</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar intra-epithepithelial lesion</span></span></span>&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75860,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18979,
      "choices": [
        {
          "id": 75876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Biopsy the lesion in your office</span></span></span></p>"
        },
        {
          "id": 75877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prescribe estrogen cream and follow up in 3 months</span></span></span></p>"
        },
        {
          "id": 75878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perform a wide local excision in the operating room</span></span></span></p>"
        },
        {
          "id": 75879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prescribe clobetasol</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman presents for her annual well woman examination and complains of vulvar pruritis. During examination, you note an area of thickened white plaque. What is the most appropriate next step? </span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-740.jpg\" style=\"height:294px; width:400px\" /></span></span></p>",
      "unique_key": "Q5380357",
      "question_audio": null,
      "question_video": null,
      "map_id": 31071,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Biopsy the lesion in your office</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><em>A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.&nbsp;</em></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions may be raised, ulcerated, pigmented, or warty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Other options</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\">Clobetasol is a local steroid which may help in several skin conditions but a biopsy is important before prescribing medication</li>\r\n\t<li style=\"text-align:justify\">Estrogen cream is prescribed for vaginal/ vulvar dryness/ dyspareunia in post menopausal women (Hormone replacement therapy). However the above image does not appear to be a menopausal related vulvar lesion</li>\r\n\t<li style=\"text-align:justify\">Once biopsy shows a vulvar malignancy, then further evaluation is done to stage the tumor (clinical staging). For microscopic lesions, a wide local excision can be done</li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><em>A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.&nbsp;</em></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions may be raised, ulcerated, pigmented, or warty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75876,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18988,
      "choices": [
        {
          "id": 75912,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Grade </span></span></span></p>"
        },
        {
          "id": 75913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor size </span></span></span></p>"
        },
        {
          "id": 75914,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depth of invasion </span></span></span></p>"
        },
        {
          "id": 75915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastasis </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56y woman is diagnosed to have a stage 2 vulvar carcinoma and she undergoes a radical vulvectomy. What is the most important prognostic factor in vulvar cancer? </span></span></p>",
      "unique_key": "Q7312482",
      "question_audio": null,
      "question_video": null,
      "map_id": 31076,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D.</span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastasis</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prognostic factors in vulval ca are:</span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymph node metastases<strong> (This is the single most important vulvar cancer predictor, since inguinal node metastasis reduces long-term survival rates by 50 percent)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FIGO Stage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesion size</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depth of invasion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resected-margin status and </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphatic vascular space involvement (LVSI)</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 710, Williams Gyn, 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75915,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18992,
      "choices": [
        {
          "id": 75928,
          "text": "<p><span style=\"font-size:12.0pt;\">Spare the saphenous vein</span></p>"
        },
        {
          "id": 75929,
          "text": "<p><span style=\"font-size:12.0pt;\">Use compression stockings</span></p>"
        },
        {
          "id": 75930,
          "text": "<p><span style=\"font-size:12.0pt;\">Transpose the sartorius muscle</span></p>"
        },
        {
          "id": 75931,
          "text": "<p><span style=\"font-size:12.0pt;\">Avoid drain placement at the time of inguinofemoral dissection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What technique can decrease the risk of lymphedema in inguinofemoral lymphadenectomy ?</span></p>",
      "unique_key": "Q5579211",
      "question_audio": null,
      "question_video": null,
      "map_id": 31079,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Spare the saphenous vein.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Explanation</span></p><p>&nbsp;</p><ul><li><span style=\"background-color:transparent;font-size:16px;\">Chronic lymphedema is a well-known complication following inguinofemoral lymphadenectomy, particularly in the management of vulvar cancer.</span></li><li><span style=\"font-size:16px;\">Preservation o the saphenous vein has been shown to reduce the incidence</span></li><li><span style=\"font-size:16px;\">Regardless, this condition is typically much more problematic with the addition of groin radiation</span></li><li><span style=\"font-size:16px;\">Supportive management is meant to minimize the edema and prevent symptomatic progression.</span></li><li><span style=\"font-size:16px;\">Foot elevation, compression stockings, and, on occasion, diuretic therapy may be helpful</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: !245, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 75928,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19004,
      "choices": [
        {
          "id": 75976,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is typically a disease of the elderly</span></span></span></p>"
        },
        {
          "id": 75977,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It commonly arises from the labia minora and clitoris</span></span></span></p>"
        },
        {
          "id": 75978,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Differential diagnoses include seborrheic keratosis and dysplastic nevi</span></span></span></p>"
        },
        {
          "id": 75979,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is more common in African American women than Caucasian women</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is INCORRECT regarding the tumor shown here involving the outer surface of the right labia minora?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-743.jpg\" style=\"height:410px; width:400px\" /></span></span></p>",
      "unique_key": "Q6165037",
      "question_audio": null,
      "question_video": null,
      "map_id": 31086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. It is more common in African American women than Caucasian women.</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a vulvar carcinoma which&nbsp;appears like a melanoma as It is pigmented</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Let us discuss all the options:&nbsp;</span></span></span>\r\n\t<ul>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: It is typically a disease of the elderly: </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is correct. Vulvla melanoma disproprtionately affects the elderly&nbsp;</span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: It commonly arises from the labia minora and clitoris. </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is also correct. The common sites are the laboa minora, majora and clitoris</span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is also correct</span></span></span><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.&nbsp;</span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diferential diagnosis include pigmented lesions like&nbsp;include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. It is more common in African American women than Caucasian women: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is incorrect. It is more common amongst whites.&nbsp;</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulval melanoma is the second most common vulvar cancer and accounts or 10 percent of all vulvar malignancies. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar melanoma disproportionately affects the elderly and develops more commonly among whites than other races. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vulvar melanoma has an overall poor prognosis, and 5-year survival rates range from 8 to 55 percent </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malignant vulvar melanomas most commonly arise from the labia minora, labia majora, or clitoris </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Some benign pigmented lesions can also be found here and include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tissue sampling is mandatory for diagnosis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 716, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75979,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18981,
      "choices": [
        {
          "id": 75884,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 mm </span></span></span></p>"
        },
        {
          "id": 75885,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 mm </span></span></span></p>"
        },
        {
          "id": 75886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 mm </span></span></span></p>"
        },
        {
          "id": 75887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">7 mm </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the maximum depth of invasion to be considered minimally invasive vulvar cancer?</span></span></p>",
      "unique_key": "Q5910416",
      "question_audio": null,
      "question_video": null,
      "map_id": 31072,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. 1 mm</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Minimally invasive vulvar cancer is Stage 1a1 where the depth of invasion is &lt; 1mm</span></span></span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851_xfx5lfx.jpg\" style=\"height:785px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742.jpg\" style=\"height:859px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>&nbsp;</li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 682, Williams Gynecology, 3rd edition</span></span></span></strong></p>",
      "correct_choice_id": 75884,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18974,
      "choices": [
        {
          "id": 75856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Femoral artery </span></span></span></p>"
        },
        {
          "id": 75857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">External iliac artery </span></span></span></p>"
        },
        {
          "id": 75858,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internal iliac artery </span></span></span></p>"
        },
        {
          "id": 75859,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Superficial pudendal artery</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The internal pudendal artery is a branch of which artery? </span></span></p>",
      "unique_key": "Q9624358",
      "question_audio": null,
      "question_video": null,
      "map_id": 31067,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. Internal iliac artery</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The internal pudendal artery is a branch of the internal iliac artery</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-739.jpg\" style=\"height:413px; width:800px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 705, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19323,
      "choices": [
        {
          "id": 77252,
          "text": "<p><span style=\"background-color:transparent;font-size:16px;\">Ultrasonography&nbsp;</span></p>"
        },
        {
          "id": 77253,
          "text": "<p><span style=\"color:#46403d;font-size:12pt;\">CT scan</span></p>"
        },
        {
          "id": 77254,
          "text": "<p><span style=\"color:#46403d;font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 77255,
          "text": "<p><span style=\"color:#46403d;font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55 years old P5L5 presented to OPD with postcoital bleeding and vaginal discharge. On examination, there is a 3 x 3cm growth involving the entire cervix. The growth does not seem to extend to the vagina and the parametrium is free. Which of the following investigations can be used for staging of cancer cervix:</span></p>",
      "unique_key": "Q8081033",
      "question_audio": null,
      "question_video": null,
      "map_id": 31089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">In 2018, the FIGO (Federation of International Gynecologists and Obstetricians) Gynecologic Oncology Committee revised the staging to allow the option of clinical, radiological, or pathological findings, as available, to assign the stage. FIGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">MRI is the best method of radiologic assessment of primary tumors greater than 10&nbsp;mm.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">T<strong>he stage is allocated after all imaging and pathology reports are available</strong>. It is not to be altered later, for example at recurrence.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">Educational Objective:</span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\">Cervical cancer is primarily a clinical staging but F<span style=\"background-color:white;font-size:12pt;\">IGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref&nbsp; : FIGO cancer report 2021</strong></span></p>",
      "correct_choice_id": 77255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19328,
      "choices": [
        {
          "id": 77272,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB1</span></span></span></p>"
        },
        {
          "id": 77273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB2</span></span></span></p>"
        },
        {
          "id": 77274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB3</span></span></span></p>"
        },
        {
          "id": 77275,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57 year old woman presents to OPD with complaint of discharge per vagina. There is a 3*3 cm visible growth on the cervix. Vagina and parametrium are uninvolved. The stage of the disease is: </span></span></p>",
      "unique_key": "Q7496682",
      "question_audio": null,
      "question_video": null,
      "map_id": 31064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Stage IB2</span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" style=\"height:1770px; width:1000px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>In this patient, the cancer is limited to the cervix and between 2 cm to 4 cm so this is 1B2</strong></li>\r\n</ul>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p><strong>Staging of cervical cancr is essential to learn as given in the table above</strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref :&nbsp; FIGO cancer report 2021</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 77273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19333,
      "choices": [
        {
          "id": 77292,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIA1</span></span></span></span></p>"
        },
        {
          "id": 77293,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIA2</span></span></span></p>"
        },
        {
          "id": 77294,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIBr</span></span></span></p>"
        },
        {
          "id": 77295,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage IIIB2r</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 50 years lady presents with foul smelling vaginal discharge since a few months. She is post-menopausal since 2 years. On examination, there is a 3.5 x 3cm growth, involving the upper part of vagina and bilateral parametrium appears free. An MRI done, shows growth involving upper vagina and parametrium, but not upto the lateral pelvic wall. The stage of the disease is:</span></span></span></p>",
      "unique_key": "Q7828206",
      "question_audio": null,
      "question_video": null,
      "map_id": 31065,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C: Stage IIBr</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FIGO CANCER REPORT 2021</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Staging of cancer cervix:&nbsp;</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical cancer is a clinical staging but certain investigations and pathology can be used to aid in staging.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per the recent FIGO staging (20021), this is Stage II B r</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&#39;r&#39; refers to findings on &#39;radiology&#39;</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong>Staging of Cervical cancer (FIGO 2021)</strong></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14px\">Educational Objectve:&nbsp;</span></strong></p>\r\n\r\n<p><strong><span style=\"font-size:14px\">Cervical cancer staging is primarily a clinical staging and it it svery important to know the staging as shown in the table above</span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak 16<sup>th</sup> edition, 2455</span></strong></span></span></p>",
      "correct_choice_id": 77294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18983,
      "choices": [
        {
          "id": 75892,
          "text": "<p>I</p>"
        },
        {
          "id": 75893,
          "text": "<p>II</p>"
        },
        {
          "id": 75894,
          "text": "<p>III</p>"
        },
        {
          "id": 75895,
          "text": "<p>IVA</p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A gynecological oncologist performs a radical vulvectomy and bilateral inguinofemoral lymph node dissection for a 3-cm invasive squamous cell carcinoma of the vulva involving the lower third of the vagina. The final histo-pathologic analysis of the specimen reveals margins and lymph nodes that are negative for cancer. Based on these findings, which International Federation of Gynecology and Obstetrics (FIGO) stage is she assigned?</span></span></p>",
      "unique_key": "Q8200397",
      "question_audio": null,
      "question_video": null,
      "map_id": 31073,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. II</span></strong></span></span></p>\r\n\r\n<p>As per the FIGO staging, the patient is Stage II</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851.jpg\" style=\"height:785px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742_VdLVY3u.jpg\" style=\"height:859px; width:600px\" /></span></span></span></p>",
      "correct_choice_id": 75893,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18997,
      "choices": [
        {
          "id": 75948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation </span></span></span></p>"
        },
        {
          "id": 75949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic exenteration </span></span></span></p>"
        },
        {
          "id": 75950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation followed by radical vulvectomy </span></span></span></p>"
        },
        {
          "id": 75951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most appropriate treatment for a 55-yearold patient with a 4-cm squamous cell carcinoma of the vulva involving the urethral meatus and a medical history significant for systemic lupus erythematosus? </span></span></p>",
      "unique_key": "Q1115546",
      "question_audio": null,
      "question_video": null,
      "map_id": 31084,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient is stage 3 vulvar cancer.&nbsp;</span></span></span></li>\r\n\t<li>The management of stage 3 vulcar cancer is modified radical vulvectomy with b/l inguinofemoral lymphadenectomy</li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of vulval cancer</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">For both <strong>stage I and stage 2</strong> disease: radical local excision and sentinel node dissection is indicated, and groin dissection is reserved for those with metastasis to the sentinel node(s).</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">For stage 3:</span></span></strong></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins. </span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Stage 4: </span></span></strong></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This patient has a stage 2 or 3 vulvar carcinoma (As lymph nodal status is not mentioned); and the best treatment option is a radical vulvectomy with b/l LN inguino-femoral dissection</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Her medical history wil not change her treatment</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 714, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></span></span></span></p>",
      "correct_choice_id": 75951,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19005,
      "choices": [
        {
          "id": 75980,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wide local excision with a 1-cm margin </span></span></span></p>"
        },
        {
          "id": 75981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wide local excision with a 2-cm margin </span></span></span></p>"
        },
        {
          "id": 75982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with right inguinofemoral lymph node dissection </span></span></span></p>"
        },
        {
          "id": 75983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical vulvectomy with bilateral inguinofemoral lymph node dissection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the most appropriate treatment for a 3-cm basal cell carcinoma of the right vulva, 2cm from the midline? </span></span></span></p>",
      "unique_key": "Q6497500",
      "question_audio": null,
      "question_video": null,
      "map_id": 31087,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Wide local excision with a 1-cm margin</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a basal cell carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma (BCC) of the vulva accounts or &lt; 2 percent of all vulvar cancers and is most commonly found in elderly women </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lesions typically arise on the labia majora, are characterized by poor pigmentation and pruritus, and often mimic eczema, psoriasis, or intertrigo. . </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal cell carcinoma is removed by radical partial vulvectomy using a minimum surgical margin of 1 cm. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphatic or distant spread is rare, but inguino femoral lymphadenectomy or Sentniel lymoh node biopsy&nbsp;is considered on clinically suspicious nodes. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 717, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19113,
      "choices": [
        {
          "id": 76412,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Barrier methods</span></span></span></span></span></p>"
        },
        {
          "id": 76413,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Copper T</span></span></span></span></span></p>"
        },
        {
          "id": 76414,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Injection DMPA</span></span></span></span></span></p>"
        },
        {
          "id": 76415,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Oral contraceptive pills </span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are counselling a patient regarding management of molar pregnancy. Which of the following contraceptive is contraindicated in patients after evacuation for molar pregnancy:</span></span></p>",
      "unique_key": "Q6119312",
      "question_audio": null,
      "question_video": null,
      "map_id": 31074,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Copper T</span></span></strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Patients are encouraged to use effective contraception during the entire interval of hCG follow-up. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Because of the potential risk of uterine perforation, bleeding, and infection, intrauterine devices should not be inserted until the patient achieves a normal hCG level. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If the patient does not desire surgical sterilization, either oral contraceptives or barrier methods should be used.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A: Barrier contraception:&nbsp;</strong></em>Barrier method of contraception is safe and can be used</span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option C:&nbsp;Inj DMPA:&nbsp;</strong></em> Injection DMPA can be used safely </span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: Combined oral contraceptive pills:&nbsp;</strong><span style=\"font-family:Arial,Helvetica,sans-serif\">Combined oral pills can be used after the hCG value has become normal</span></em></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong><em><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></em></strong></span></p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:14px\">Post molar evacuation, contraception is advised till the period of beta hCG surveillance</span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:14px\">All contraceptives are safe except Intra-Uterine Devices.&nbsp;</span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:14px\">Combined OCPs can be started after beta hCG values return to normal</span></strong></em></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: berek and novak, 16<sup>th</sup> edition, page 2772</span></span></strong></span></span></span></p>",
      "correct_choice_id": 76413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19114,
      "choices": [
        {
          "id": 76416,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></span></span></p>"
        },
        {
          "id": 76417,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Epithelioid trophoblastic tumor (ETT)</span></span></span></span></span></p>"
        },
        {
          "id": 76418,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
        },
        {
          "id": 76419,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Placental site trophoblastic tumor (PSTT)</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic neoplasia includes <strong>all Except</strong>:</span></span></p>",
      "unique_key": "Q9378548",
      "question_audio": null,
      "question_video": null,
      "map_id": 31075,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ans. C. Molar pregnancy </span></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">&nbsp; &nbsp; &nbsp; &nbsp;Modified WHO Classification of GTD</span></span></span></strong></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image.png\" style=\"height:301px; width:608px\" /></p>\r\n\r\n<p><em><strong><span style=\"color:#1c1d1e; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\">Gestational Trophoblastic&nbsp; Neoplasias include the following:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">Invasive mole</span></li>\r\n\t<li><span style=\"font-size:14px\">Choriocarcinoma</span></li>\r\n\t<li><span style=\"font-size:14px\">Placental site trophoblatic tumor</span></li>\r\n\t<li><span style=\"font-size:14px\">Epitheloid trophoblastic tumor</span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">Molar pregnancy (partial anc complete) aren&#39;t included under gestational trophoblastic neoplasias.&nbsp;</span></strong></em></p>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<p><em><strong><span style=\"color:#1c1d1e\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\">Gestational Trophoblastic&nbsp; Neoplasias include the following:&nbsp;</span></span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\">Invasive mole</span></li>\r\n\t<li><span style=\"font-size:14px\">Choriocarcinoma</span></li>\r\n\t<li><span style=\"font-size:14px\">Placental site trophoblatic tumor</span></li>\r\n\t<li><span style=\"font-size:14px\">Epitheloid trophoblastic tumor</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Ref: FIGO cancer report 2021</span></span></span></strong></span></span></p>",
      "correct_choice_id": 76418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19120,
      "choices": [
        {
          "id": 76440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 1</span></span></span></p>"
        },
        {
          "id": 76441,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 2</span></span></span></p>"
        },
        {
          "id": 76442,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 3</span></span></span></p>"
        },
        {
          "id": 76443,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 4 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman has been admitted after 3 increasing weekly hCG values, 2 months after molar evacuation. On examination, cervix, vagina is healthy, uterus is normal size. Her Hb is 10g%, chest X-ray is shown below. What stage of GTN does she have?</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/10_INAODUi.jpg\" style=\"height:232px; width:300px\" /></span></span></p>",
      "unique_key": "Q2925310",
      "question_audio": null,
      "question_video": null,
      "map_id": 31078,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Stage 3</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">TABLE 1.</span></strong><strong>&nbsp;<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FIGO staging and classification for gestational trophoblastic neoplasia (GTN) is as shown in the table</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">As the patient in the given scenario has typical canon ball lung metastases on the chest X-Ray, she is Stage 3.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Also note that lung metastases in GTN signifies a good prognosis and is very responsive to single agent chemotherapy with MEthotrexate being the drug of choice.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg\" style=\"height:504px; width:1000px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Staging of GTN:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg\" style=\"height:504px; width:1000px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><strong>Ref: FIGO cancer report 2021, Berek &amp; novak, 16th ed page 2775</strong></span></span></p>",
      "correct_choice_id": 76442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19122,
      "choices": [
        {
          "id": 76448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Actinomycin D injection 5-day regimen</span></span></span></p>"
        },
        {
          "id": 76449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO regimen </span></span></span></p>"
        },
        {
          "id": 76450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate-folinic acid 8-day regimen</span></span></span></p>"
        },
        {
          "id": 76451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old woman develops GTN&nbsp; 10 months after abortion. Her beta hCG value is 1,20,000 mIU/mL. The chest X ray shows metastasis. The appropriate treatment for her would be:</span></span></p>",
      "unique_key": "Q2334859",
      "question_audio": null,
      "question_video": null,
      "map_id": 31080,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. EMA-CO regimen </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">From the information we have, her WHO prognostic score (See table below) would be: </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age: 22: Scor 0</span></span></span></li>\r\n\t\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous pregnancy: Abortion: Score: 1</span></span></span></li>\r\n\t\t<li><span style=\"font-size:16px\">Interval from index pregnancy: 8 months: Score: 2</span></li>\r\n\t\t<li><span style=\"font-size:16px\">hCG level: 120000: Score: 4</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Lung mets: Score 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Size of tumor: Not mentioned</span></li>\r\n\t\t<li><span style=\"font-size:16px\">No of mets: Not mentiones</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Previous chemotherapy: not mentioned</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:16px\">Total score = 7 which is HIGH RISK (Score &gt; 6 is high risk)</span></li>\r\n\t<li><span style=\"font-size:16px\">High risk requires multi agent chemotherapy with EMACO&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">World Health Organization scoring system based on prognostic factors modified as FIGO score</span></span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/12_A3tO6F5.jpg\" style=\"height:719px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A risk score of 6 and below is classified as low risk and above 6 is considered high risk. </span></span></span></span></span></strong></em></li>\r\n\t<li><em><strong><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy </span></span></span></strong></em></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option A:&nbsp;</strong></em>Actinomycin D injection 5-day regimen: Actinomycin D is not the drug of choice in GTN. Methotrexate is the drug of choice in low risk GTN</span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option C: </strong></em>Methotrexate folinic acid 8 day regime: This is the preferred drug in low risk GTN. This patient has high risk GTN as her score is 7.&nbsp;</span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Option D:&nbsp; </strong></em>Hysterectomy: Hysterectomy is rarely done in GTN. Indications include excessive bleeding or uterine perforation. Rarely in chemoresistance, hysterectomy can be resorted to.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">The WHO prognostic scoring system in GTN determines the type of chemotherapy</span></li>\r\n\t<li><span style=\"font-size:16px\">If the score is &le;&nbsp;6, the patient requires single agent (Methotrexate) chemotherpay. This is given as 4 doses (1mg/Kg) alternating with 4 doses of folinic acid (0.1mg/kg) every 2-3 weeks.&nbsp;</span></li>\r\n\t<li><span style=\"font-size:16px\">If the score &gt; 7 the patient requires multiagent chemotherapy (EMACO). This includes&nbsp;<span dir=\"ltr\" lang=\"EN-IN\">etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021</span></strong></span></span></p>",
      "correct_choice_id": 76449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19123,
      "choices": [
        {
          "id": 76452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EMA-CO regimen </span></span></span></p>"
        },
        {
          "id": 76453,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Embolisation of vaginal nodule</span></span></span></p>"
        },
        {
          "id": 76454,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate-folinic acid 8 day regimen</span></span></span></p>"
        },
        {
          "id": 76455,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year woman develops GTN, 6 months after molar evacuation. On speculum examination, there is a reddish blue nodule in vagina. Her hCG is 24,000mIU/mL. chest XRay is normal. Mhe most appropriate treatment for her is</span></span></p>",
      "unique_key": "Q7183202",
      "question_audio": null,
      "question_video": null,
      "map_id": 31081,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Methotrexate-folinic acid 8 day regimen</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">As per the WHO prognostic scoring for GTN (shown in the table below, her score is 3</span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:16px\">Age 22:0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Post molar evacuation:&nbsp;&nbsp;0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Interval: 6 months: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">hCG 24000: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Mets: 1</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Site of mets: vagina: 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Prev chemo: 0</span></li>\r\n\t\t<li><span style=\"font-size:16px\">Size not provided</span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:16px\">Therefore single agent multidose chemotherapy (Methotrexate with folinic acd) is preferred&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/14.jpg\" style=\"height:700px; width:900px\" /></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">A risk score of 6 and below is classified as low risk and above 6 is considered high risk.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">First-line single agent chemotherapy regimens for low-risk gestational trophoblastic neoplasia include methorexate (alternating with folinic acid). 2nd line drug is Actinomycin D.&nbsp;</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/15.jpg\" style=\"height:430px; width:900px\" /></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option A: EMA-CO:</strong> This is the regime of choice in high risk GTN (Score of 7 and above)</span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option B: Embolization of vaginal nodule:</strong>&nbsp;Vaginal metastases may bleed profusely and torrential bleeding can occur following biopsy of a lesion. To control the bleeding, plication, packing the vagina or performing a wide local excision. Angiographic embolization of the hypogastric arteries can also be done.&nbsp;</span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Option D: Hysterectomy </strong>is not an option in vaginal metastases in GTN</span></p>\r\n\r\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><span style=\"font-size:16px\"><strong>Ref: FIGO Cancer Report 2021</strong></span></em></span></p>",
      "correct_choice_id": 76454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19124,
      "choices": [
        {
          "id": 76456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 weekly chemotherapy, response monitored by CA 125</span></span></span></p>"
        },
        {
          "id": 76457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 weekly chemotherapy, response monitored by CA 125</span></span></span></p>"
        },
        {
          "id": 76458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 weekly chemotherapy, response monitored by hCG</span></span></span></p>"
        },
        {
          "id": 76459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 weekly chemotherapy, response monitored by hCG</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year woman with stage 2 GTN is receiving methotrexate-based chemotherapy. How frequently is chemotherapy given and what marker is used to assess response to treatment?</span></span></p>",
      "unique_key": "Q8303905",
      "question_audio": null,
      "question_video": null,
      "map_id": 31082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 2 weekly chemotherapy, response monitored by Hcg</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse</span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Both EMACO and Methotrexate are given 2 weekly</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><strong>Option A and B: </strong>Monitoring is not by Ca 125. Ca 125 is a marker for epithelial ovarrianc ancer but is also found to be raised in fibroid, endometriosis, pregnancy, PID and genital TB</span></li>\r\n\t<li><span style=\"font-size:16px\"><strong>Option D: </strong>Methotrexate is given 2 weekly as per the recent FIGO cancer report of 2021.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:16px\">Educational Objective:&nbsp;</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Both EMACO and Methotrexate are given 2 weekly</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">EMACO is given for high risk GTN</span></span></li>\r\n\t<li><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Methotrexate is given for low risk GTN</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO cancer report 2021, Berek and Novak 16th ed Page 2757</span></strong></span></span></p>",
      "correct_choice_id": 76458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19125,
      "choices": [
        {
          "id": 76460,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given for one cycle followed by hCG follow up </span></span></span></p>"
        },
        {
          "id": 76461,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given for 6 cycles followed by hCG follow up</span></span></span></p>"
        },
        {
          "id": 76462,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given till hCG undetectable followed by hCG follow up</span></span></span></p>"
        },
        {
          "id": 76463,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding chemotherapy in GTN, which of the following is true?</span></span></p>",
      "unique_key": "Q6523055",
      "question_audio": null,
      "question_video": null,
      "map_id": 31083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Administration of single-agent chemotherapy (generally 8-day MTX-FA for low risk GTN) every 2 weeks until hCG is undetected and then three consolidation courses to reduce the risk of relapse is recommended </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Patients who require combination chemotherapy (EMACO for high risk GTN) must be treated intensively to attain remission. Combination chemotherapy should be given as often as toxicity permits until the patient achieves three consecutive normal hCG levels. After normal hCG levels are attained, at least three additional courses of chemotherapy are administered to reduce the risk of relapse.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Educational Objective:&nbsp;</em></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"color:#000000; font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><em>Chemotherapy for GTN (for low risk: Mtx-FA and high risk: EMA-CO), it is given 2 weekly till hCG levels are undetectable followed by 2-3 consolidation doses&nbsp;</em></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek &amp; novak 16 edition, page 2785, 2786</span></strong></span></span></p>",
      "correct_choice_id": 76463,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18976,
      "choices": [
        {
          "id": 75864,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0 </span></span></span></p>"
        },
        {
          "id": 75865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 </span></span></span></p>"
        },
        {
          "id": 75866,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30</span></span></span></p>"
        },
        {
          "id": 75867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What percentage of vulvar cancers is positive for human papillomavirus (HPV)?</span></span></p>",
      "unique_key": "Q4561529",
      "question_audio": null,
      "question_video": null,
      "map_id": 31069,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 50</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>Risk factors of vulvar cancer are</p>\r\n\r\n<ul>\r\n\t<li>More common in older age (&gt; 60y) and white race</li>\r\n\t<li>Increased association with obesity, HTN, diabetes and nulliparoty</li>\r\n\t<li>Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget&#39;s disease, squamous cell hyperplasia, condyloma acuminata</li>\r\n\t<li>HPV (high risk type 16, 18): in 50% of cases. A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.&nbsp;</li>\r\n\t<li>Chronic pruritis, chronic irritation of the vulva</li>\r\n\t<li>Vulvar intra-epithepithelial lesion&nbsp;(VIN)</li>\r\n</ul>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p>HPV (high risk type 16, 18): is seen in 50% of cases of vulvar cancer.&nbsp; A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 708, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75867,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18990,
      "choices": [
        {
          "id": 75920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphocele</span></span></span></p>"
        },
        {
          "id": 75921,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphedema </span></span></span></p>"
        },
        {
          "id": 75922,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin infection</span></span></span></p>"
        },
        {
          "id": 75923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wound dehiscence </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 64y lady undergoes radical vulvectomy with inguinofermoral lymoh node dissection for vulvar cancer. What is the most common complication of an inguinofemoral lymph node dissection? </span></span></span></p>",
      "unique_key": "Q7083985",
      "question_audio": null,
      "question_video": null,
      "map_id": 31077,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Lymphedema</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Following inguino-femoral lymph node dissection, the following complications are noted:&nbsp;</span></span></span></p>\r\n\r\n<ol>\r\n\t<li>Lymphedema:&nbsp;<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amongst all complications, the most common complication of inguino-femoral LN dissection is a lymohedema</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphocele</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin infection</span></span></span></li>\r\n\t<li>Groin necrosis</li>\r\n\t<li>Groin seperation</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 715, Williams Gynecology, 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75921,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18993,
      "choices": [
        {
          "id": 75932,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiation alone</span></span></span></p>"
        },
        {
          "id": 75933,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation</span></span></span></p>"
        },
        {
          "id": 75934,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Close observation </span></span></span></p>"
        },
        {
          "id": 75935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic lymph node dissection </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You perform a radical vulvectomy with bilateral inguinofemoral lymphadenectomy on a woman with a 4-cm squamous cell carcinoma tumor of the vulva. Margins are negative for cancer, but there are three positive lymph nodes. What is the most appropriate treatment?</span></span></p>",
      "unique_key": "Q7268729",
      "question_audio": null,
      "question_video": null,
      "map_id": 31085,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Chemoradiation</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a stage III vulvar cancers (Tumor of any size with or without extension to adjacent perineal structures (lower 1/3rd urethera, lower 1/3rd vagina, anus) with positive inguino-femoral nodes.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women with stage III vulvar cancer are treated with surger followed by adjuvant radiation therapy directed to both groins and the pelvis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The addition of platinum-based chemotherapy concurrent with radiation therapy is also now given, and hence the best answer here is chemo-radiation</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 714, Williams Gyn, 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19009,
      "choices": [
        {
          "id": 75996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics </span></span></span></p>"
        },
        {
          "id": 75997,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with marsupialization &nbsp;</span></span></span></p>"
        },
        {
          "id": 75998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with excision of the gland</span></span></span></p>"
        },
        {
          "id": 75999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54-year-old woman presents with the persistent vulvar mass seen in the picture below and complaints of dyspareunia.&nbsp; What is the most appropriate management?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-744.jpg\" style=\"height:270px; width:400px\" /></span></span></p>",
      "unique_key": "Q7702582",
      "question_audio": null,
      "question_video": null,
      "map_id": 31088,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C.</span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incision and drainage with excision of the gland</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a Bartholin gland cyst</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bartholin gland enlargement in a woman older than 40 years and recurrent cysts or abscesses warrants a biopsy or excision as there could be an underlying adenocarcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a young woman, the treatment of choice of a Bartholin duct cyst is marsupialiation</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 718, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 75998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30882,
      "choices": [
        {
          "id": 123406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare</span></span></span></p>"
        },
        {
          "id": 123407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is primarily used for staging and does not influence the management of vulvar carcinoma</span></span></span></p>"
        },
        {
          "id": 123408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is used to identify the 1<sup>st</sup> lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive</span></span></span></p>"
        },
        {
          "id": 123409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;A 52-year-old woman presents with a suspicious vulvar lesion. A biopsy confirms the presence of squamous cell carcinoma of the vulva. Clinical exam and imaging show no evidence of metastases. Her healthcare team decided to perform a sentinel lymph node biopsy (SLNB) to assess lymph node involvement. Which of the following is a true statement?</span></span></span></p>",
      "unique_key": "Q8398497",
      "question_audio": null,
      "question_video": null,
      "map_id": 31070,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. SLNB is used to identify the 1<sup>st</sup> lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Sentinel LN Biopsy in Vulvar Carcinoma</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces the requirement of LN dissection in vulvar carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main route of spread of vulvar carcinoma is lymphatic spread</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done by lymphoscintigraphy with Tc99 labelled isosulfan blue dye/ indocyanine fluorescent green</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Groin incision made 10 mins later</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colored node is excised and examined</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If negative: No lymphadenectomy needs to be done</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If positive: B/l inguinofemoral lymphadenectomy is done</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare: This is a wrong statement as lymphatic spread is the most common route of spread of vulvar cancers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is primarily used for staging and does not influence the management of vulvar carcinoma: This is a wrong statement as SLNB is mainly done to reduce the risk of LN dissection thereby preventing complications</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy: This is a wrong statement as SLNB is not the mainstay of treatment. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Sentinel LN Biopsy in Vulvar Carcinoma</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces the requirement of LN dissection in vulvar carcinoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main route of spread of vulvar carcinoma is lymphatic spread</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: page 686, Williams Gynecology, 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 123408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}